General Information：
Human Long Arg3 Insulin-like Growth Factor-I(Long-R3-IGF-I) is an 83 amino acid analog of human IGF-I comprising the complete human IGF-I sequence with the substitution of an Arg for the Glu at position 3 (hence R3), and a 13 amino acid extension peptide at the N-terminus. Scientists have engineered this analog with the express purpose of increasing biological activity.
Human Long-R3-IGF-I is significantly more potent than human IGF-I in vitro. The enhanced potency is due to the markedly decreased binding of human Long-R3-IGF-I to IGF binding proteins which normally inhibit the biological actions of IGFs.
Expression Host: E. coli
Molecular Mass:
The recombinant human Long-R3-IGF-I has a calculated molecular mass of 9111Da.
Formulation:
Lyophilized from sterile PBS , pH 7.2, and 5 % mannitol are added as protectants before lyophilization.
Quality Control
Purity: > 95 % as as determined by the following methods:
(a) RP-HPLC analysis
(b) SDS-PAGE silver-stained gel analysis
Bio-activity:
The ED50 of recombinant human Long R3 IGF-I, calculated by the dose-dependant proliferation of murine BALBC 3T3 cells, is less
than 1.0ng/ml, corresponding to a specific activity of 1.0×106IU/mg.
Endotoxin:
﹤ 1.0 EU/mg as determined by the LAL method. Product specification：
100ug/vial；500ug/vial；1mg/vial.
Store at：
2-8oC for two years，Avoid repeated freeze and thaw.
關鍵字： igf;細胞因子;胰島素樣生長因子1;長鏈胰島素樣生長因子1;
杭州普羅醫(yī)藥科技有限公司是一家集基因工程重組蛋白質研發(fā)，生產及銷售于一體的高新技術企業(yè)。擁有標準化的實驗室，生產車間，檢驗室及倉庫，面積1500平方。公司能夠為客戶提供從克級到公斤級的重組蛋白以及基因工程酶的生產和服務。
公司擁有一支由專業(yè)的博士及碩士組成的技術團隊，能夠為客戶提供一整套的技術解決方案；公司的質量控制部門是一支受過嚴格GMP培訓及ISO培訓的質量技術人員，能夠通過專業(yè)技術檢測對對公司產品進行嚴格的質量控制。